About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: July 2011
Weekly Roundup – 7/15/11
I had hoped to have some good stuff posted for you this week, but between a bout of something nasty combined with travel, it didn’t happen. Oh well, it is summer and things (like the nation’s well-being as overseen by … Continue reading
Posted in Weekly Roundup
2 Comments
To Have and to Have Not – Is there an Emerging Digital Literati Divide in Medicine?
I was reminded as I tried to set up my new scale complete with WiFi that will feed into my iPad my weight, body mass index and with accompanying blood pressure cuff – my blood pressure. The app in the … Continue reading
Posted in Uncategorized
1 Comment
While Media Goes Even More Social, DDMAC Still is Not – Enter Video Calling….
Remembering back to childhood, many will recall that visions of the future included flying cars (still waiting…), personal jetpacks (still waiting) and video calling (it’s here!). Video calling has been around for a while, thanks to Skype. And the new … Continue reading
Posted in FDA Policy, New and Social Media
3 Comments
Upward Mobililty
Early last month, in the wake of the Apple announcement of changes coming to iOS-5, I wrote a posting about how the future might be impacted by cloud computing, increased access to Twitter and considerations around the mobile access to … Continue reading
Posted in Uncategorized
1 Comment
Checking in on Pharma and YouTube
Generally speaking, the use of YouTube by the pharmaceutical industry has not been reflective of industry’s best communications work. The medium of video has so much potential and yet it remains largely been untapped. (See Eye on FDA “What Would … Continue reading
Posted in New and Social Media, Video
4 Comments